Jane Street’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Jane Street’s Portfolio LHDX Stock Details LHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-30,400	Closed	-$231K	–	11067
2021 Q3	$231K	Buy	+30,400	New	+$256K	﹤0.01%	8642

Other funds holding LHDX

Eclipse Ventures Palo Alto, California $2.57B AUM

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Resolute Advisors San Francisco, California $242M AUM 52.95% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

Jane Street's LHDX Position: Q1 2023 in Review

Jane Street sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2023, closing a stake of 26,831 shares — an estimated $2.98K sold.

Jane Street first reported a position in LHDX in Q4 2022 and held it in 1 quarter. The position peaked at $2.98K in Q4 2022. 6 funds tracked by Wall St. Rank hold LHDX as of Q1 2023.

Jane Street reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Jane Street sold 26,831 Lucira Health, Inc. Common Stock shares in Q1 2023, an estimated $2.98K.
Jane Street first reported a position in Lucira Health, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Jane Street's Lucira Health, Inc. Common Stock position peaked at $2.98K in Q4 2022.
6 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.